These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 25849839)
1. Proximal tubular dysfunction in a HIV-1 patient with coadministered tenofovir disoproxil-fumarate and ibuprofen. Duim AR; Rokx C; van Gorp EC; Rijnders BJ AIDS; 2015 Mar; 29(6):746-8. PubMed ID: 25849839 [No Abstract] [Full Text] [Related]
2. Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients. Casado JL; Del Rey JM; Bañón S; Santiuste C; Rodriguez M; Moreno A; Perez-Elías MJ; Liaño F; Moreno S J Acquir Immune Defic Syndr; 2016 Aug; 72(4):416-22. PubMed ID: 26962850 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir. Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820 [TBL] [Abstract][Full Text] [Related]
4. Tenofovir disoproxil fumarate-induced Fanconi's syndrome during HIV postexposure prophylaxis. Penot P; Gosset C; Verine J; Molina JM AIDS; 2016 May; 30(8):1311-3. PubMed ID: 27128332 [No Abstract] [Full Text] [Related]
5. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study. Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300 [TBL] [Abstract][Full Text] [Related]
6. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity? Saumoy M; Vidal F; Peraire J; Sauleda S; Vea AM; Viladés C; Ribera E; Richart C AIDS; 2004 Aug; 18(12):1741-2. PubMed ID: 15280790 [No Abstract] [Full Text] [Related]
7. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir. Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504 [TBL] [Abstract][Full Text] [Related]
8. Renal and Bone Toxicity with the Use of Tenofovir: Understanding at the End. Casado JL AIDS Rev; 2016; 18(2):59-68. PubMed ID: 27230467 [TBL] [Abstract][Full Text] [Related]
9. Cluster headache-like symptoms during treatment with tenofovir disoproxil fumarate and emtricitabine. Citerne Q; Boyer L; Moreau E; Garon J; Gillet P; Petitpain N AIDS; 2019 Jul; 33(9):1535-1536. PubMed ID: 31259768 [No Abstract] [Full Text] [Related]
10. Renal safety of tenofovir disoproxil fumarate. Sax PE; Gallant JE; Klotman PE AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508 [TBL] [Abstract][Full Text] [Related]
11. Clinic-Based Evaluation of a Point-of-Care Creatinine Assay to Screen for Renal Impairment Among HIV-Positive Patients Receiving Tenofovir Disoproxil Fumarate. Dorward J; Yende-Zuma N; Samsunder N; Karim QA; Drain PK; Garrett N J Acquir Immune Defic Syndr; 2018 Apr; 77(4):e36-e39. PubMed ID: 29271830 [No Abstract] [Full Text] [Related]
12. Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys? Aloy B; Tazi I; Bagnis CI; Gauthier M; Janus N; Launay-Vacher V; Deray G; Tourret J AIDS Rev; 2016; 18(4):184-192. PubMed ID: 27438578 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal Assessment of Proximal Tubular Dysfunction in HIV Seropositive and Seronegative Persons: Correlates and Implications. Sheets KM; Atta MG; Fine DM; Zook K; Mcfall AM; Estrella MM; Schwartz GJ; Lucas GM J Acquir Immune Defic Syndr; 2017 May; 75(1):45-51. PubMed ID: 28151777 [TBL] [Abstract][Full Text] [Related]
14. Renal proximal tubular dysfunction due to tenofovir in a patient with chronic hepatitis B monoinfection. Harkisoen S; Arends JE; Hoepelman AI; van Erpecum KJ Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):e67-9. PubMed ID: 25746138 [No Abstract] [Full Text] [Related]
15. Life-threatening rhabdomyolysis and Fanconi syndrome related to tenofovir disoproxil fumarate administration in an HIV-infected patient. Favarel-Garrigues M; Hentzien M; Berger JL; Brunet A; Bani-Sadr F Med Mal Infect; 2020 Feb; 50(1):93-94. PubMed ID: 31506209 [No Abstract] [Full Text] [Related]
16. Reversal of tenofovir induced nephrotoxicity: case reports of two patients. Some F; Koech M; Chesire E; Kigen G Pan Afr Med J; 2017; 27():126. PubMed ID: 28904656 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration. Ezinga M; Wetzels JF; Bosch ME; van der Ven AJ; Burger DM Antivir Ther; 2014; 19(8):765-71. PubMed ID: 24584104 [TBL] [Abstract][Full Text] [Related]